News Headlines

  1. Health Equity Research Goes Global—Without Waiting For Perfect Data 3/4/2026

    Value in Health Regional Issues published a special research collection showing meaningful progress in health equity across regions with varying data environments and policy needs.

  2. International Study Confirms Universal Digital Health Framework 3/4/2026

    Value in Health published an international study showing the PICOTS‑ComTeC framework is an effective standard for defining patient-facing digital health interventions.

  3. ISPOR Announces New Executive Director 3/4/2026

    ISPOR—The Professional Society for Health Economics and Outcomes Research has announced that Kelly Saldaña has been appointed as executive director for the ISPOR Institute for Healthcare Transformation.

  4. Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment 2/26/2026

    Quotient Sciences, a leading integrated CRDMO, announced an extended commercial supply partnership with Ipsen, a global biopharmaceutical company, to manufacture a treatment for Fibrodysplasia Ossificans Progressiva (FOP), an ultra-rare disease affecting fewer than 1,000 people worldwide.

  5. Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner 2/19/2026

    Sygnature Discovery, a leading drug discovery contract research organisation (CRO), has today announced a strategic brand relaunch, including a new website, cementing its position as a global drug discovery partner.

  6. Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials 2/18/2026

    Suvoda, a clinical trial technology company, took decisive steps in 2025 toward a more connected and streamlined clinical trial experience for both patients and sites. The company’s merger with Greenphire marked a pivotal moment in that journey, strengthening Suvoda’s ability to tackle persistent trial operational challenges with a more unified approach. Together with continued product innovation and deployment of AI tools, Suvoda closed the year with growing momentum toward a single, cohesive ecosystem that reduces complexity across the clinical trial lifecycle.

  7. Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix® 2/18/2026

    Suvoda, a global clinical trial technology company, today announced that its IRT (Interactive Response Technology) software, also known as RTSM (Randomization and Trial Supply Management), has been recognized as a Leader in Everest Group’s PEAK Matrix® assessment for RTSM technology.

  8. Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer 2/12/2026

    Altasciences announced today that Chris Perkin has been appointed as a member of the company’s Board of Directors, effective Tuesday, February 24, 2026. Following a leadership transition that has been underway for the past 12 months, Marie-Hélène Raigneau, President of the company since April 2025, has been appointed Chief Executive Officer, also effective Tuesday, February 24, 2026.

  9. AI Agent Enhances Principal Investigator Oversight Of eCOA Data 2/3/2026

    Explore how AI agents are better assisting principal investigators with oversight of electronic clinical outcome assessment (eCOA) data.

  10. Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes 2/3/2026

    Managing trial master files is often manual, time-consuming, and error-prone. Learn how AI agents can help automate TMF workflows and streamline clinical operations.